City of London Investment Group plc (LON:CLIG) has announced its full-year results for FY’20. As previously indicated, over a volatile year, FUM grew to $5.51bn. This..
Blackrock World Mining Trust plc (LON:BRWM) has provided the following portfolio update: All information is at 31 August 2020 and unaudited.Performance at month end with net..
Diurnal Group plc (LON:DNL) is a commercial-stage specialty pharmaceutical company focused on diseases of the endocrine system. Its products are targeting rare conditions where medical need..
Blackrock Income and Growth Investment Trust plc (LON:BRIG) has provided the following portfolio update: All information is at 31 August 2020 and unaudited. Performance at month end with..
Union Jack Oil plc (LON:UJO), a UK-focused onshore hydrocarbon production, development and exploration company, has announced that it has raised £7 million by way of an..
Cadence Minerals plc (LON:KDNC) has noted that Hastings Technology Metals (ASX:HAS), Cadence’s joint venture partner at the Yangibana Rare Earth Project in the Gascoyne region of..
Ferro-Alloy Resources plc (LON:FAR) CEO Nick Bridgen joins DirectorsTalk in this video interview to discuss the raising of funds. Nick explains what has been raised over..
Surface Transforms plc (LON:SCE) is the topic of conversation when Robin Byde Research Director at Zeus Capital joins DirectorsTalk. Robin talks us through the major contract..
Boku Inc (LON:BOKU) CEO Jon Prideaux joins DirectorsTalk to discuss half year trading results. Jon talks us through the highlights, explains what the acquisition of Fortumo..
NEXT plc (LON:NXT) has announced its results for the half year ending July 2020. CHIEF EXECUTIVE’S REVIEW HEADLINES Performance in the First Half ● Profit before..
Gresham House plc, (LON: GHE) the specialist alternative asset manager, reports a strong 17% growth in Assets Under Management (AUM) in the first half of the..
Morses Club PLC (LON:MCL), an established provider of non-standard financial services, has provided the following update on trading further to the statement issued on 10th August..
N4 Pharma Plc (LON:N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for vaccines and cancer treatments, has announced its unaudited interim results for..
